Hyperphagia in Prader-Willi Syndrome
Rare Disease
Prevalence
0.5 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Carbetocin | ACADIA PHARMACEUTICALS INC (ACAD) |
Frequently asked questions
How many drugs are in development for Hyperphagia in Prader-Willi Syndrome?
BioSniper tracks 1 drug in development for Hyperphagia in Prader-Willi Syndrome across 1 company.
How many clinical trials target Hyperphagia in Prader-Willi Syndrome?
There are 3 clinical trials targeting Hyperphagia in Prader-Willi Syndrome tracked by BioSniper.
What is the prevalence of Hyperphagia in Prader-Willi Syndrome?
The estimated prevalence of Hyperphagia in Prader-Willi Syndrome is approximately 0.5 per 100,000 population.
Deep-dive into Hyperphagia in Prader-Willi Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis